What is Nephro-Tech?
Nephro-Tech, Inc., established in 1992, is a dedicated provider of high-quality pharmaceuticals and specialized dietary supplements tailored for dialysis patients. The company's product portfolio includes essential prescription iron supplements and renal vitamins, formulated to address nutrient depletion common during dialysis treatments. Nephro-Tech's core mission revolves around delivering cost-effective and convenient solutions for healthcare providers and individuals managing chronic kidney disease, emphasizing accessibility in its offerings.
How much funding has Nephro-Tech raised?
Nephro-Tech has raised a total of $79K across 1 funding round:
Debt
$79K
Debt (2021): $79K with participation from PPP
What's next for Nephro-Tech?
With the recent influx of substantial expansion capital, Nephro-Tech is strategically positioned for significant growth. This funding is expected to fuel advancements in product development, enhance manufacturing capabilities, and broaden market reach, particularly within the specialized segment of chronic kidney disease management. The company's focus on affordability and patient well-being suggests a trajectory aimed at solidifying its market leadership and potentially exploring new therapeutic areas or delivery systems to further support the dialysis patient community.
See full Nephro-Tech company page
